Camila 0.35 MG tablet 28S
Ended Awarded
- Contract number
- SPE2DB26FXSGT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,232
Award facts
- Contract value 100% obligated
- $7,232.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Camila 0.35 mg tablets (28-count) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, non-set-aside delivery order carries a ceiling value of $7,232.11 under firm fixed-price terms. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract extending through December 2026 that serves as a comprehensive global pharmaceutical support vehicle.
The SPE2DX contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Camila, an oral contraceptive medication, reflects the company's role as a critical vendor in the federal medical procurement supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's consistent receipt of competitively awarded contracts through the DLA demonstrates its capability to meet federal pharmaceutical procurement requirements at various order values.
Quick answers
Who was awarded contract SPE2DB26FXSGT?
SPE2DB26FXSGT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FXSGT worth?
The government has obligated $7,232 on SPE2DB26FXSGT.
Is contract SPE2DB26FXSGT an order under another contract?
Yes. SPE2DB26FXSGT is a delivery order under SPE2DB25D7060, an indefinite delivery contract.
Was contract SPE2DB26FXSGT competed?
The extent of competition for SPE2DB26FXSGT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award